tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
CNS Pharmaceuticals Announces New CEO Appointment
PremiumCompany AnnouncementsCNS Pharmaceuticals Announces New CEO Appointment
2M ago
CNS Pharmaceuticals CEO John Climaco steps down, Rami Levin succeeds
Premium
The Fly
CNS Pharmaceuticals CEO John Climaco steps down, Rami Levin succeeds
2M ago
CNS Pharmaceuticals Increases Authorized Shares for Growth
Premium
Company Announcements
CNS Pharmaceuticals Increases Authorized Shares for Growth
3M ago
CNS Pharmaceuticals upgraded to Buy at Maxim on TPI-287 roadmap
PremiumThe FlyCNS Pharmaceuticals upgraded to Buy at Maxim on TPI-287 roadmap
5M ago
CNS Pharmaceuticals upgraded to Buy from Hold at Maxim
Premium
The Fly
CNS Pharmaceuticals upgraded to Buy from Hold at Maxim
5M ago
CNS Pharmaceuticals reports Q2 EPS ($6.42) vs. ($4,049.20) last year
Premium
The Fly
CNS Pharmaceuticals reports Q2 EPS ($6.42) vs. ($4,049.20) last year
6M ago
Upcoming Stock Splits This Week (July 21 to July 25) – Stay Invested
PremiumMarket NewsUpcoming Stock Splits This Week (July 21 to July 25) – Stay Invested
7M ago
CNS Pharmaceuticals announces 1-for-12 reverse stock split
Premium
The Fly
CNS Pharmaceuticals announces 1-for-12 reverse stock split
7M ago
CNS Pharmaceuticals Posts Investor Presentation on Brain Cancer
Premium
Company Announcements
CNS Pharmaceuticals Posts Investor Presentation on Brain Cancer
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100